logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
19/10/2026
Market news: Eli Lilly's (LLY.N) OMVOH drug meets primary endpoint in pediatric ulcerative colitis trial.
Latest
2 m ago
Zizhu Hi-Tech (002058.SZ): Subsidiary intends to apply to the National Equities Exchange and Quotations for termination of stock listing
4 m ago
Kingfa Sci. & Tech. (600143.SH) Chairman Proposes RMB 300 Million to RMB 500 Million Share Buyback
7 m ago
Xuefeng Technology (603227.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 371 million yuan, a year-on-year decrease of 6.69%.
8 m ago
Green Power (000537.SZ): Completed power generation of 6.615 billion kWh in Q3, up 12.98% year on year.
12 m ago
Fengyuan Pharmaceutical (000153.SZ): Peramivir Injection Receives Drug Registration Certificate
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.